The Prognostic Value of the Controlling Nutritional Status Score in Patients with Myelodysplastic Syndrome

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2022 Aug 8

PMID 35939237

Authors

Jin Qian

Jing Wang

Feng Cheng

Hong-Feng Guo

Jun Xia

Xin Zhou

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the prognostic value of the controlling nutritional status score (CONUT) in patients with myelodysplastic syndrome (MDS).

Methods: The clinical data of 81 newly diagnosed MDS patients treated with decitabine in the hematology ward of our hospital from October 2009 to September 2020 were analyzed retrospectively. According to the ROC curve of overall survival (OS), the best cutoff value of CONUT was obtained. MDS patients were divided into high CONUT score group and low CONUT score group according to the best cut-off value, and their clinical characteristics and survival were analyzed.

Results: Among the 81 patients with MDS, there were 32 cases in the high CONUT score group and 49 cases in low CONUT score group. Compared with the low CONUT group, the high CONUT group had lower levels of hemoglobin, lymphocyte count, albumin, and total cholesterol (P = 0.037, < 0.001, 0.009, < 0.001). The median OS of low and high CONUT groups were 17.2 and 11.0 months (P = 0.017). According to the results of univariate and multivariate survival analysis of OS, thrombocytopenia, high CONUT score, and medium and high risk IPSS-R score were independent prognostic factors.

Conclusion: High CONUT score is associated with low hemoglobin in patients with MDS. High CONUT score indicates poor OS and it is an independent prognostic factor in patients with MDS.

Citing Articles

The controlling nutritional status score as a predictor of survival in hematological malignancies: a systematic review and meta-analysis.

Lu G, Li Q Front Nutr. 2024; 11:1402328.

PMID: 38938670 PMC: 11208478. DOI: 10.3389/fnut.2024.1402328.

References

Rollison D, Howlader N, Smith M, Strom S, Merritt W, Ries L . Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood. 2008; 112(1):45-52. DOI: 10.1182/blood-2008-01-134858. View

Toyokawa T, Kubo N, Tamura T, Sakurai K, Amano R, Tanaka H . The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer. 2016; 16:722. PMC: 5013653. DOI: 10.1186/s12885-016-2696-0. View

Toyokawa G, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T . Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma. J Thorac Dis. 2017; 9(9):2942-2951. PMC: 5708442. DOI: 10.21037/jtd.2017.07.108. View

Liu X, Zhang D, Lin E, Chen Y, Li W, Chen Y . Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer. BMC Cancer. 2018; 18(1):699. PMC: 6022496. DOI: 10.1186/s12885-018-4616-y. View

Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K . The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set. Ann Surg Oncol. 2018; 26(2):456-464. DOI: 10.1245/s10434-018-07121-w. View

Kamiya T, Ito C, Fujita Y, Ogura S, Mizuno K, Sakurai A . The prognostic value of the controlling nutritional status score in patients with multiple myeloma. Leuk Lymphoma. 2020; 61(8):1894-1900. DOI: 10.1080/10428194.2020.1749608. View

Ureshino H, Kusaba K, Kidoguchi K, Sano H, Nishioka A, Itamura H . Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma. Ann Hematol. 2018; 98(2):465-471. DOI: 10.1007/s00277-018-3502-7. View

Sakurai A, Nakazato T . The prognostic value of the controlling nutritional status score in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia related changes treated with azacitidine. Leuk Lymphoma. 2020; 61(12):2995-2997. DOI: 10.1080/10428194.2020.1791847. View

10.

Ellis M, Baraf L, Shaish A, Har-Zahav A, Harats D, Ashur-Fabian O . Alteration of lipids and the transcription of lipid-related genes in myelodysplastic syndromes via a TP53-related pathway. Exp Hematol. 2012; 40(7):540-547.e1. DOI: 10.1016/j.exphem.2012.02.003. View

11.

Yamamoto M, Saito H, Uejima C, Tanio A, Tada Y, Matsunaga T . Prognostic Value of Combined Tumor Marker and Controlling Nutritional Status (CONUT) Score in Colorectal Cancer Patients. Yonago Acta Med. 2019; 62(1):124-130. PMC: 6437416. View

12.

Jacobs N, Holtan S, Porrata L, Markovic S, Tefferi A, Steensma D . Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count. Am J Hematol. 2010; 85(3):160-3. DOI: 10.1002/ajh.21618. View

13.

Hejazi M, Manser A, Frobel J, Kundgen A, Zhao X, Schonberg K . Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes. Haematologica. 2015; 100(5):643-52. PMC: 4420213. DOI: 10.3324/haematol.2014.118679. View

14.

Yikilmaz A, Akinci S, Bakanay S, Dilek I . Does the platelet‑to‑lymphocyte ratio have a prognostic effect in patients with myelodysplastic syndrome?. Bratisl Lek Listy. 2020; 121(6):422-427. DOI: 10.4149/BLL_2020_068. View

15.

Nagata A, Kanemasa Y, Sasaki Y, Nakamura S, Okuya T, Funasaka C . Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma. Hematol Oncol. 2020; 38(3):309-317. DOI: 10.1002/hon.2732. View

16.

Sze S, Pellicori P, Kazmi S, Rigby A, Cleland J, Wong K . Prevalence and Prognostic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure: A Comparison With Body Mass Index. JACC Heart Fail. 2018; 6(6):476-486. DOI: 10.1016/j.jchf.2018.02.018. View

17.

Harimoto N, Yoshizumi T, Inokuchi S, Itoh S, Adachi E, Ikeda Y . Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study. Ann Surg Oncol. 2018; 25(11):3316-3323. DOI: 10.1245/s10434-018-6672-6. View